The Discounted Cash Flow (DCF) valuation of Vivos Therapeutics Inc (VVOS) is (126.88) USD. With the latest stock price at 0.59 USD, the upside of Vivos Therapeutics Inc based on DCF is -21604.6%.
Based on the latest price of 0.59 USD and our DCF valuation, Vivos Therapeutics Inc (VVOS) is a sell. selling VVOS stocks now will result in a potential gain of 21604.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.9% - 6.4% | 5.6% |
| Long-term Growth Rate | 3.0% - 4.6% | 3.8% |
| Fair Price | (902.72) - (69.88) | (126.88) |
| Upside | -153103.4% - -11944.3% | -21604.6% |